Nuveen Real Asset Income & Growth Fund (JRI) officer exercises 7,872 rights
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Nuveen Real Asset Income & Growth Fund’s Chief Administrative Officer David J. Lamb exercised subscription rights to acquire 7,872 shares of common stock at an exercise price of $12.40 per share. These rights, classified as derivative securities, were fully exercised, leaving no remaining subscription rights outstanding after the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
7,872 shares exercised/converted
Mixed
1 txn
Insider
LAMB DAVID J
Role
Chief Administrative Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| X | Subscription Right | 7,872 | $12.40 | $98K |
Holdings After Transaction:
Subscription Right — 0 shares (Direct)
Footnotes (1)
FAQ
What insider transaction did Nuveen Real Asset Income & Growth Fund (JRI) report?
Nuveen Real Asset Income & Growth Fund reported that Chief Administrative Officer David J. Lamb exercised subscription rights to acquire 7,872 shares of common stock at $12.40 per share. This Form 4 filing reflects an in-the-money derivative exercise, not an open-market stock purchase or sale.
Who is the insider in JRI’s latest Form 4 and what is their role?
The insider is David J. Lamb, who serves as Chief Administrative Officer of Nuveen Real Asset Income & Growth Fund. He reported exercising derivative subscription rights into common stock, illustrating a compensation or rights-related transaction rather than a discretionary market trade.
Was David J. Lamb’s JRI transaction a stock purchase or sale in the market?
The transaction was not an open-market purchase or sale. Instead, David J. Lamb executed an in-the-money exercise of subscription rights, a type of derivative security, to acquire 7,872 common shares at a predetermined exercise price of $12.40 per share.
What happened to David J. Lamb’s JRI subscription rights after the exercise?
After the exercise, the reported balance of subscription rights was zero. The Form 4 shows that all 7,872 rights were converted into common stock, leaving no remaining subscription right derivatives outstanding for this specific grant following the transaction.
Does the JRI Form 4 indicate any remaining derivative positions for the insider?
The filing’s derivative summary is empty after this exercise, indicating no remaining derivative positions from the reported subscription rights. The only derivative transaction disclosed is the exercise of 7,872 rights into common stock at $12.40 per share.